Why are you looking at Srisai Biopharmaceutical Solutions?
Email me when a Srisai Biopharmaceutical Solutions recompete window opens.
Capability
Service linesMEDICAL LABORATORIES
Work mix: 18% prime · 82% sub · primary NAICS 621511 / PSC Q999 MEDICAL- OTHER
Where they win
2 agenciesRecompete exposure: Low · 1 in 24mo
Srisai Biopharmaceutical Solutions has an estimated $160K in contracts returning to market over the next 24 months.
Agency buyer map
2 buyersRecompete exposure
LowSrisai Biopharmaceutical Solutions has an estimated $160K in contracts returning to market over the next 24 months.
Srisai Biopharmaceutical Solutions teams with
1Partners from federal subaward / teaming records (public).
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Srisai Biopharmaceutical Solutions hold?
Srisai Biopharmaceutical Solutions (UEI DMAXAMHK9XL3) shows $406K across 14 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Srisai Biopharmaceutical Solutions have?
Srisai Biopharmaceutical Solutions shows $406K across 14 award actions. SCOUT tracks 1 incumbent recompetes ($160K) returning to market in the next 24 months.
Which agencies does Srisai Biopharmaceutical Solutions work with?
Srisai Biopharmaceutical Solutions’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (90%), Department of Defense (DOD) (10%).
What is the UEI for Srisai Biopharmaceutical Solutions?
The Unique Entity ID (UEI) for Srisai Biopharmaceutical Solutions is DMAXAMHK9XL3.
Does Srisai Biopharmaceutical Solutions have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Srisai Biopharmaceutical Solutions — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.